Suchergebnisse - "Editorial"

PubPharm (1.357)

1

Interpreting HER2-low at the lower end : Added challenge to the pathologists

enthalten in: Annals of diagnostic pathology | 2024

von Khoury, T.

2

Breast cancer therapy in China : Introducing the Special Collection

enthalten in: Cancer | 2024

von Wang, X. | O'Regan, R.

3

Adjuvant Alectinib in ALK-Rearranged NSCLC - Here and Now

enthalten in: The New England journal of medicine | 2024

von Passaro, A. | Peters, S.

4

Translational Research in ROS1-Positive NSCLC : Are We Moving Out of the Six Blind Men and the Elephant Stage?

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Lee, J. | Nagasaka, M.

5

Resistance Mechanisms in ROS1-Positive Lung Cancer : New Insight into a Rare but Clinically Important Entity

enthalten in: Clinical chemistry | 2024

von von Itzstein, M. | Gerber, D.

CommentOn: Clin Chem. 2024 Apr 3;70(4):629-641. - PMID 38416709

6

Hepatocellular carcinoma, vascular endothelial growth factor receptors-targeting agents, and hypertension : A much more complicated relationship than expected

enthalten in: Cancer | 2024

von Porta, C. | Negri, F. | Cosmai, L.

7

Chemotherapy and Osimertinib Combination Should Not Be the First-Line Treatment for All Advanced EGFR+ NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Lim, S. | Lee, J. | Cho, B.

8

Chemotherapy and Osimertinib Combination Should Be the First-Line Treatment for All Advanced EGFR+ NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Chen, L. | Lee, A. | Nagasaka, M. | +1

9

Partners in Crime : Co-Occurring Genetic Alterations in EGFR-Mutant NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Le, X.

10

Risk/benefit of BTK/venetoclax combos : the context matters!

enthalten in: Blood | 2024

von Seymour, J.

CommentOn: Blood. 2024 Feb 15;143(7):582-591. - PMID 37971194

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[136]